Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Klein

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Methods in Enzymology|January 1, 1991
Quantitative structure-activity relationships and molecular graphics in evaluation of enzyme-ligand interactionsC Hansch, T E Klein
Clinical Pharmacology and Therapeutics|January 29, 2011
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkM V Relling, T E Klein
Biopolymers|March 10, 1999
Computational investigations of structural changes resulting from point mutations in a collagen-like peptideT E Klein, C C Huang
The Pharmacogenomics Journal|January 22, 2004
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge baseT E Klein, R B Altman
Clinical Pharmacology and Therapeutics|August 24, 2007
The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB)R P Owen, T E Klein, R B Altman
Clinical Pharmacology and Therapeutics|July 25, 2014
Interpreting the CYP2D6 results from the International Tamoxifen Pharmacogenetics ConsortiumM A Province, R B Altman, T E Klein
Il Farmaco; Edizione Scientifica|December 1, 1987
Concanavalin X-phenyl beta-D-glucopyranoside interactions. A molecular graphics-QSAR analysisM Recanatini, T E Klein, R Langridge, et al.
Clinical Pharmacology and Therapeutics|December 23, 2006
The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledgeA E Hodge, R B Altman, T E Klein
Clinical Pharmacology and Therapeutics|April 20, 2013
Clinical implementation of pharmacogenetics: more than one gene at a timeJ A Johnson, T E Klein, M V Relling
Clinical Pharmacology and Therapeutics|May 28, 2013
Challenges in the pharmacogenomic annotation of whole genomesR B Altman, M Whirl-Carrillo, T E Klein
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Methods in Enzymology|January 1, 1991
Quantitative structure-activity relationships and molecular graphics in evaluation of enzyme-ligand interactionsC Hansch, T E Klein
Clinical Pharmacology and Therapeutics|January 29, 2011
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkM V Relling, T E Klein
Biopolymers|March 10, 1999
Computational investigations of structural changes resulting from point mutations in a collagen-like peptideT E Klein, C C Huang
The Pharmacogenomics Journal|January 22, 2004
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge baseT E Klein, R B Altman
Clinical Pharmacology and Therapeutics|August 24, 2007
The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB)R P Owen, T E Klein, R B Altman
Clinical Pharmacology and Therapeutics|July 25, 2014
Interpreting the CYP2D6 results from the International Tamoxifen Pharmacogenetics ConsortiumM A Province, R B Altman, T E Klein
Il Farmaco; Edizione Scientifica|December 1, 1987
Concanavalin X-phenyl beta-D-glucopyranoside interactions. A molecular graphics-QSAR analysisM Recanatini, T E Klein, R Langridge, et al.
Clinical Pharmacology and Therapeutics|December 23, 2006
The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledgeA E Hodge, R B Altman, T E Klein
Clinical Pharmacology and Therapeutics|April 20, 2013
Clinical implementation of pharmacogenetics: more than one gene at a timeJ A Johnson, T E Klein, M V Relling
Clinical Pharmacology and Therapeutics|May 28, 2013
Challenges in the pharmacogenomic annotation of whole genomesR B Altman, M Whirl-Carrillo, T E Klein
Pageof 7